Package 16571-852-03

Brand: memantine hydrochloride

Generic: memantine
NDC Package

Package Facts

Identity

Package NDC 16571-852-03
Digits Only 1657185203
Product NDC 16571-852
Description

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-852-03)

Marketing

Marketing Status
Marketed Since 2025-06-01
Brand memantine hydrochloride
Generic memantine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4ece2bda-d26f-494f-93df-bc53c494caf9", "openfda": {"unii": ["JY0WD0UA60"], "rxcui": ["996594", "996603", "996609", "996615"], "spl_set_id": ["a282fbed-8304-458e-a0e9-5eaccc95339b"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-852-03)", "package_ndc": "16571-852-03", "marketing_start_date": "20250601"}], "brand_name": "Memantine Hydrochloride", "product_id": "16571-852_4ece2bda-d26f-494f-93df-bc53c494caf9", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["N-methyl-D-aspartate Receptor Antagonist [EPC]", "NMDA Receptor Antagonists [MoA]"], "product_ndc": "16571-852", "generic_name": "memantine", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Memantine Hydrochloride", "active_ingredients": [{"name": "MEMANTINE HYDROCHLORIDE", "strength": "7 mg/1"}], "application_number": "ANDA206032", "marketing_category": "ANDA", "marketing_start_date": "20250601", "listing_expiration_date": "20261231"}